Clinical benefit with cisplatin, hydroxyurea and 5-fluorouracil/leucovorin in advanced pancreatic adenocarcinoma

Eur J Cancer. 1997 Apr;33(4):696-7. doi: 10.1016/s0959-8049(96)00438-8.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase II
  • Letter

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cisplatin / administration & dosage
  • Female
  • Fluorouracil / administration & dosage
  • Humans
  • Hydroxyurea / administration & dosage
  • Male
  • Middle Aged
  • Palliative Care
  • Pancreatic Neoplasms / drug therapy*

Substances

  • Cisplatin
  • Fluorouracil
  • Hydroxyurea